FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
The United Laboratories International Holdings Limited Stock AnalysisComprehensive stock analysis for The United Laboratories International Holdings Limited (ULIHF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisULIHF
ULIHF
The United Laboratories International Holdings Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ULIHF
Home🔹Stocks🔹The United Laboratories International Holdings Limited

The United Laboratories International Holdings Limited

ULIHF•OTC

The United Laboratories International Holdings Limited

ULIHF•OTC
Market cap
$3.16B
Sentiment

Your view on ULIHF

Mkt Cap
$3.16B
Sentiment
Your view
ULIHF
The United Laboratories International Holdings Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ULIHF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About The United Laboratories International Holdings Limited

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Hoi Shan Tsoi
Headquarters
6 Fuk Wang Street, Yuen Long, HK
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Hoi Shan Tsoi
Headquarters
6 Fuk Wang Street, Yuen Long, HK
Description

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News